Welcome To Latest IND >> Fastest World News NEW DELHI: The stock market is set for a 360 degrees transition in the coming days, with a potential recovery following a period of uncertainty and sluggish growth, according to a recent report by Morgan Stanley...
Welcome To Latest IND >> Fastest World News NEW DELHI: The stock market is set for a 360 degrees transition in the coming days, with a potential recovery following a period of uncertainty...
Welcome To Latest IND >> Fastest World News NEW DELHI: US President Donald Trump's approach in the second term on tariff announcements has been perceived by markets as a more gradualist approach compared...
Welcome To Latest IND >> Fastest World News CBSE Class 10 and 12 admit card 2025: The Central Board of Secondary Education (CBSE) will begin the Class 10 and 12 board exams 2025 on February...
Welcome To Latest IND >> Fastest World News Akshay Kumar has finally delivered a much-needed success with Sky Force, as the film earned Rs 75 crore in just five days at the box...
Welcome To Latest IND >> Fastest World News Coldplay wrapped up the Indian leg of their Music of the Spheres on a high with 5 gigs in the country. The band even made...
Welcome To Latest IND >> Fastest World News The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD).The approval was based on data from a late-stage study, which showed that Ozempic helped cut the risk of death from chronic kidney disease and major cardiac events by 24%, the company said, Reuters reported. With the US FDA nod, the drug, chemically known as semaglutide, became the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease. Last year, the FDA had approved...
Welcome To Latest IND >> Fastest World News NEW DELHI: The stock market is set for a 360 degrees transition in the coming days, with a potential recovery following a period of uncertainty...
Welcome To Latest IND >> Fastest World News The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart...